Policy Papers Series

Documents

Order by : Name | Date | Hits | [ Descendent ]

Policy Paper 2: Gambling - Two sides of the same coin Policy Paper 2: Gambling - Two sides of the same coin

hot!
Date added: 07/16/2013
Date modified: 03/06/2017
Filesize: 1.14 MB
Downloads: 14337

July 2013

This second policy brief in the AR policy paper series, 'Gambling: two sides of the same coin', makes the case for a more comprehensive and coherent national and European policy approach to all gambling settings and gambling providers. The paper discusses clinical relevance and recent developments in the field and also identifies a wide variety of actions and policy options which give the necessary emphasis to public health interests related to gambling activity.

NB: Spam filters may prevent this document from downloading on some institutional computers. If you have problems, please write to fmbooth@clinic.cat for a PDF copy.

Policy paper 5. Cannabis: From prohibition to regulation. Policy paper 5. Cannabis: From prohibition to regulation.

hot!
Date added: 05/12/2014
Date modified: 03/06/2017
Filesize: 655.22 kB
Downloads: 18267

Apr 2014

Drawing on global and European experience in regulating tobacco and alcohol, the 5th ALICE RAP Policy Paper makes the case for why current prohibitionist approaches need to be changed and how legal regulatory cannabis policies can be crafted that protect public health, wealth and well‐being.

NB: Spam filters may prevent this document from downloading on some institutional computers. If you have problems, please write to fmbooth@clinic.cat for a PDF copy.

Policy Paper 4. Prescription opioids and Public Health. Policy Paper 4. Prescription opioids and Public Health.

hot!
Date added: 12/13/2013
Date modified: 03/08/2016
Filesize: 1.02 MB
Downloads: 18683

Dec 2013

This AR policy paper outlines the key issues for policy-makers considering the possible risks of increasing opioid prescription and how to balance the need for adequate medical control of pain against possible problematic non-medical use of these substances. Three key considerations for evidence-based policy are highlighted in conclusion.